Dr. Agarwal's Health Care Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 4.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The company received a Show Cause Notice dated May 18, 2026 from the GST & Central Excise Office in Chennai alleging discrepancies in its GST returns for financial year 2023-24. The discrepancies include differences in output turnover, short payment of tax under RCM, excess and ineligible ITC claims, and non-compliance with e-invoicing requirements. The GST authorities have demanded Rs. 20.50 crores including interest and penalty. The company has 30 days to respond and states it is examining the notice and will submit a reply within the prescribed time. The company asserts it does not foresee any material impact on its financials or operations.
Although the company claims no significant impact, the Rs. 20.50 crore GST demand represents a material potential liability. The outcome of this notice could affect profitability if the demand is upheld, though the company appears confident in its response.